Labinger Barry

Exec VP & CCO at HUMAN GENOME SCIENCES INC · on record since Aug 18, 2006
Director at ANADYS PHARMACEUTICALS INC · on record since Mar 15, 2011
EVP, Biosciences Div. at Emergent BioSolutions Inc. · on record since Aug 14, 2013
Director at Checkmate Pharmaceuticals, Inc. · on record since Aug 10, 2020
President and CEO at Checkmate Pharmaceuticals, Inc. · on record since Aug 10, 2020

Insider trading activity of Labinger Barry

Transactions on record: 66; since Aug 16, 2005

Open-market buys: 0

Open-market sells: 15; $7.7M

Companies traded: 4; last filing Aug 6, 2021

Figures computed from official regulatory filings — .

Companies where Labinger Barry has traded

Checkmate Pharmaceuticals, Inc.2 tx · Aug 6, 2021
Emergent BioSolutions Inc.20 tx · $2.6M · Nov 17, 2015
HUMAN GENOME SCIENCES INC42 tx · $7M · Mar 12, 2012
ANADYS PHARMACEUTICALS INC2 tx · May 27, 2011

Track record of Labinger Barry

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Labinger Barry

Co-insiders of Labinger Barry

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
Checkmate Pharmaceuticals, Inc.Listing unverified	Aug 6, 2021	AwardD (derivative)	85,950	0.00 USD	—	SEC
Checkmate Pharmaceuticals, Inc.Listing unverified	Aug 10, 2020	AwardD (derivative)	445,819	0.00 USD	—	SEC
Emergent BioSolutions Inc.Listing on record	Nov 17, 2015	Sell	-3,376	36.50 USD	$123.2K	SEC
Emergent BioSolutions Inc.Listing on record	Nov 13, 2015	ExerciseD (derivative)	-10,094	0.00 USD	—	SEC
Emergent BioSolutions Inc.Listing on record	Nov 13, 2015	ExerciseD (derivative)	-10,095	0.00 USD	—	SEC
Emergent BioSolutions Inc.Listing on record	Nov 13, 2015	Exercise	10,094	20.94 USD	$211.4K	SEC
Emergent BioSolutions Inc.Listing on record	Nov 13, 2015	Sell	-6,564	35.51 USD	$233.1K	SEC
Emergent BioSolutions Inc.Listing on record	Nov 13, 2015	Exercise	9,373	28.09 USD	$263.3K	SEC
Emergent BioSolutions Inc.Listing on record	Nov 13, 2015	Exercise	10,095	20.94 USD	$211.4K	SEC
Emergent BioSolutions Inc.Listing on record	Nov 13, 2015	Sell	-10,094	36.00 USD	$363.4K	SEC
Emergent BioSolutions Inc.Listing on record	Nov 13, 2015	Sell	-9,373	35.50 USD	$332.7K	SEC
Emergent BioSolutions Inc.Listing on record	Nov 13, 2015	Sell	-10,095	35.50 USD	$358.4K	SEC
Emergent BioSolutions Inc.Listing on record	Nov 13, 2015	Other	-1,671	35.88 USD	$60K	SEC
Emergent BioSolutions Inc.Listing on record	Nov 13, 2015	ExerciseD (derivative)	-9,373	0.00 USD	—	SEC
Emergent BioSolutions Inc.Listing on record	Mar 12, 2015	Other	-1,594	29.00 USD	$46.2K	SEC
Emergent BioSolutions Inc.Listing on record	Mar 12, 2015	AwardD (derivative)	21,517	0.00 USD	—	SEC
Emergent BioSolutions Inc.Listing on record	Mar 12, 2015	Award	10,762	0.00 USD	—	SEC
Emergent BioSolutions Inc.Listing on record	Dec 29, 2014	Other	-1,577	24.41 USD	$38.5K	SEC
Emergent BioSolutions Inc.Listing on record	Mar 12, 2014	AwardD (derivative)	28,119	0.00 USD	—	SEC
Emergent BioSolutions Inc.Listing on record	Mar 12, 2014	Award	14,060	28.09 USD	$394.9K	SEC
Emergent BioSolutions Inc.Listing on record	Feb 3, 2014	Award	15,142	0.00 USD	—	SEC
Emergent BioSolutions Inc.Listing on record	Feb 3, 2014	AwardD (derivative)	30,284	0.00 USD	—	SEC
HUMAN GENOME SCIENCES INCListing unverified	Mar 12, 2012	AwardD (derivative)	108,000	0.00 USD	—	SEC
HUMAN GENOME SCIENCES INCListing unverified	Jul 27, 2011	Exercise	7,306	10.11 USD	$73.9K	SEC
HUMAN GENOME SCIENCES INCListing unverified	Jul 27, 2011	ExerciseD (derivative)	-8,000	0.00 USD	—	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Checkmate Pharmaceuticals, Inc.Listing unverified	Aug 6, 2021	AwardD (derivative)	85,950	0.00 USD	—	SEC
Checkmate Pharmaceuticals, Inc.Listing unverified	Aug 10, 2020	AwardD (derivative)	445,819	0.00 USD	—	SEC
Emergent BioSolutions Inc.Listing on record	Nov 17, 2015	Sell	-3,376	36.50 USD	$123.2K	SEC
Emergent BioSolutions Inc.Listing on record	Nov 13, 2015	ExerciseD (derivative)	-10,094	0.00 USD	—	SEC
Emergent BioSolutions Inc.Listing on record	Nov 13, 2015	ExerciseD (derivative)	-10,095	0.00 USD	—	SEC
Emergent BioSolutions Inc.Listing on record	Nov 13, 2015	Exercise	10,094	20.94 USD	$211.4K	SEC
Emergent BioSolutions Inc.Listing on record	Nov 13, 2015	Sell	-6,564	35.51 USD	$233.1K	SEC
Emergent BioSolutions Inc.Listing on record	Nov 13, 2015	Exercise	9,373	28.09 USD	$263.3K	SEC
Emergent BioSolutions Inc.Listing on record	Nov 13, 2015	Exercise	10,095	20.94 USD	$211.4K	SEC
Emergent BioSolutions Inc.Listing on record	Nov 13, 2015	Sell	-10,094	36.00 USD	$363.4K	SEC
Emergent BioSolutions Inc.Listing on record	Nov 13, 2015	Sell	-9,373	35.50 USD	$332.7K	SEC
Emergent BioSolutions Inc.Listing on record	Nov 13, 2015	Sell	-10,095	35.50 USD	$358.4K	SEC
Emergent BioSolutions Inc.Listing on record	Nov 13, 2015	Other	-1,671	35.88 USD	$60K	SEC
Emergent BioSolutions Inc.Listing on record	Nov 13, 2015	ExerciseD (derivative)	-9,373	0.00 USD	—	SEC
Emergent BioSolutions Inc.Listing on record	Mar 12, 2015	Other	-1,594	29.00 USD	$46.2K	SEC
Emergent BioSolutions Inc.Listing on record	Mar 12, 2015	AwardD (derivative)	21,517	0.00 USD	—	SEC
Emergent BioSolutions Inc.Listing on record	Mar 12, 2015	Award	10,762	0.00 USD	—	SEC
Emergent BioSolutions Inc.Listing on record	Dec 29, 2014	Other	-1,577	24.41 USD	$38.5K	SEC
Emergent BioSolutions Inc.Listing on record	Mar 12, 2014	AwardD (derivative)	28,119	0.00 USD	—	SEC
Emergent BioSolutions Inc.Listing on record	Mar 12, 2014	Award	14,060	28.09 USD	$394.9K	SEC
Emergent BioSolutions Inc.Listing on record	Feb 3, 2014	Award	15,142	0.00 USD	—	SEC
Emergent BioSolutions Inc.Listing on record	Feb 3, 2014	AwardD (derivative)	30,284	0.00 USD	—	SEC
HUMAN GENOME SCIENCES INCListing unverified	Mar 12, 2012	AwardD (derivative)	108,000	0.00 USD	—	SEC
HUMAN GENOME SCIENCES INCListing unverified	Jul 27, 2011	Exercise	7,306	10.11 USD	$73.9K	SEC
HUMAN GENOME SCIENCES INCListing unverified	Jul 27, 2011	ExerciseD (derivative)	-8,000	0.00 USD	—	SEC